Skip to content

Clinical trials

Terminated Phase 3 Atrial Fibrillation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Status: Terminated Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20074
20083
20091
20102
20111
20121
20131
20153
20161
20171
20181
20192
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic3
Sanofi3
Biosense Webster, Inc.2
Advanz Pharma1
AstraZeneca1
Atrial Fibrillation Network1
Bayer1
Beth Israel Deaconess Medical Center1
Boston Scientific Corporation1
C. R. Bard1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation29
Stroke3
Arrhythmias, Cardiac2
Anemia1
Anemia, Iron-Deficiency1
Atrial Flutter1
Cardiovascular Diseases1
Constriction, Pathologic1
Coronary Artery Disease1
Heart Diseases1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.